Different durations of cognitive stimulation therapy for Alzheimer's disease: a systematic review and meta-analysis

Clin Interv Aging. 2019 Jul 12:14:1243-1254. doi: 10.2147/CIA.S210062. eCollection 2019.

Abstract

Objective: We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to evaluate the efficacy of cognitive stimulation therapy (CST) of different durations for Alzheimer's disease (AD).

Methods: A comprehensive search was carried out in three databases. The primary outcome was Mini-Mental State Examination (MMSE) score. We conducted a meta-analysis with Review Manager, version 5.3 and assessed the methodological quality of the included studies using the Cochrane Collaboration Recommendations assessment tool.

Results: Treatment effects from the meta-analysis showed that CST plus acetylcholinesterase inhibitors (ChEIs) was better than the control assessed by MMSE. In addition, the meta-analysis indicated that long-term CST was better than short-term or maintenance CST.

Conclusion: Our study confirmed that the combination of CST and drug treatment for AD is effective in AD, regardless of whether short-term CST, maintenance CST, or long-term CST is used. The long-term CST appears to be more effective.

Keywords: Alzheimer’s disease; cognitive stimulation therapy; cognitive symptom; meta-analysis.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Alzheimer Disease / complications
  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / therapy*
  • Cholinesterase Inhibitors / therapeutic use
  • Cognition Disorders / etiology
  • Cognition Disorders / therapy*
  • Cognitive Behavioral Therapy / methods*
  • Humans
  • Randomized Controlled Trials as Topic
  • Social Behavior

Substances

  • Cholinesterase Inhibitors